Transcutaneous Auricular Vagal Nerve Stimulation Inhibits Hypothalamic P2Y1R Expression and Attenuates Weight Gain Without Decreasing Food Intake in Zucker Diabetic Fatty Rats

Overview

Journal Sci Prog

Publisher Sage Publications

Specialty Science

Date 2021 Apr 13

PMID 33848220

Citations 6

Authors

Yutian Yu

Xun He

Jinling Zhang

Chunzhi Tang

Peijing Rong

Affiliations

Soon will be listed here.

Abstract

Zucker diabetic fatty (ZDF) rats that harbor a mutation in the leptin receptor innately develop type 2 diabetes (T2D) with obesity. Transcutaneous auricular vagal nerve stimulation (taVNS) has an antidiabetic effect in ZDF rats. However, the underlying mechanisms of the weight-gain attenuating effect in ZDF rats by taVNS is still unclear. This study aimed to assess whether the weight-gain attenuating effect of taVNS in ZDF rats is associated with changes in the central nervous system (CNS) expression of P2Y1 receptors (P2Y1R). Adult male ZDF rats were subjected to taVNS and transcutaneous non-vagal nerve stimulation (tnVNS). Their food intake and body weight were recorded daily and weekly, respectively. P2Y1R expression in the hypothalamus, amygdala, and hippocampus was evaluated by western blotting. Hypothalamic P2Y1R expressing cells were detected using immunohistochemistry. Naïve ZDF rats were much heavier ( < 0.05) than their lean littermates (ZL rats), with elevated hypothalamic P2Y1R expression ( < 0.05). Further, taVNS but not tnVNS attenuated weight gain ( < 0.05) without decreasing food intake ( > 0.05) and suppressed hypothalamic P2Y1R expression in ZDF rats ( < 0.05). Moreover, P2Y1R showed major expression in astrocytes of ZDF rats' hypothalamus. ZDF rats innately develop obesity associated with elevated hypothalamic P2Y1R expression. taVNS attenuates weight gain in ZDF rats without changes in food intake, suggesting increased energy expenditure. Whether the reduced hypothalamic P2Y1R expression in response to taVNS is mechanistically linked to the increased energy expenditure remains to be determined.

Citing Articles

Transcutaneous vagus nerve stimulation modulates depression-like phenotype induced by high-fat diet via P2X7R/NLRP3/IL-1β in the prefrontal cortex.

Li S, Zhang Y, Wang Y, Zhang Z, Xin C, Wang Y CNS Neurosci Ther. 2024; 30(5):e14755.

PMID: 38752512 PMC: 11097256. DOI: 10.1111/cns.14755.

Transcutaneous auricular vagus nerve stimulation as a novel therapy connecting the central and peripheral systems: a review.

Zou N, Zhou Q, Zhang Y, Xin C, Wang Y, Claire-Marie R Int J Surg. 2024; 110(8):4993-5006.

PMID: 38729100 PMC: 11326027. DOI: 10.1097/JS9.0000000000001592.

Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome.

Zhang S, He H, Wang Y, Wang X, Liu X Sci Rep. 2023; 13(1):7721.

PMID: 37173458 PMC: 10182028. DOI: 10.1038/s41598-023-34746-z.

A comparative investigation on H3K27ac enhancer activities in the brain and liver tissues between wild boars and domesticated pigs.

Zhou Z, Jiang T, Zhu Y, Ling Z, Yang B, Huang L Evol Appl. 2022; 15(8):1281-1290.

PMID: 36051459 PMC: 9423090. DOI: 10.1111/eva.13461.

Transcutaneous auricular vagus nerve stimulation augments postprandial inhibition of ghrelin.

Kozorosky E, Lee C, Lee J, Nunez Martinez V, Padayachee L, Stauss H Physiol Rep. 2022; 10(8):e15253.

PMID: 35441808 PMC: 9020171. DOI: 10.14814/phy2.15253.

References

de Lartigue G . Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol. 2016; 594(20):5791-5815. PMC: 5063945. DOI: 10.1113/JP271538. View

Bolborea M, Dale N . Hypothalamic tanycytes: potential roles in the control of feeding and energy balance. Trends Neurosci. 2013; 36(2):91-100. PMC: 3605593. DOI: 10.1016/j.tins.2012.12.008. View

Castle M, Comoli E, Loewy A . Autonomic brainstem nuclei are linked to the hippocampus. Neuroscience. 2005; 134(2):657-69. DOI: 10.1016/j.neuroscience.2005.04.031. View

Schwartz M, Porte Jr D . Diabetes, obesity, and the brain. Science. 2005; 307(5708):375-9. DOI: 10.1126/science.1104344. View

Salm A, Smithson K, Hatton G . Lactation-associated redistribution of the glial fibrillary acidic protein within the supraoptic nucleus. An immunocytochemical study. Cell Tissue Res. 1985; 242(1):9-15. DOI: 10.1007/BF00225557. View

Burneo J, Faught E, Knowlton R, Morawetz R, Kuzniecky R . Weight loss associated with vagus nerve stimulation. Neurology. 2002; 59(3):463-4. DOI: 10.1212/wnl.59.3.463. View

Neary N, Goldstone A, Bloom S . Appetite regulation: from the gut to the hypothalamus. Clin Endocrinol (Oxf). 2004; 60(2):153-60. DOI: 10.1046/j.1365-2265.2003.01839.x. View

Pardo J, Sheikh S, Kuskowski M, Surerus-Johnson C, Hagen M, Lee J . Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond). 2007; 31(11):1756-9. PMC: 2365729. DOI: 10.1038/sj.ijo.0803666. View

Burnstock G, Gentile D . The involvement of purinergic signalling in obesity. Purinergic Signal. 2018; 14(2):97-108. PMC: 5940632. DOI: 10.1007/s11302-018-9605-8. View

10.

Rutecki P . Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990; 31 Suppl 2:S1-6. DOI: 10.1111/j.1528-1157.1990.tb05843.x. View

11.

Apovian C, Aronne L, Bessesen D, McDonnell M, Murad M, Pagotto U . Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015; 100(2):342-62. DOI: 10.1210/jc.2014-3415. View

12.

Suzuki K, Jayasena C, Bloom S . Obesity and appetite control. Exp Diabetes Res. 2012; 2012:824305. PMC: 3415214. DOI: 10.1155/2012/824305. View

13.

Ter Horst G, de Boer P, Luiten P, van Willigen J . Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience. 1989; 31(3):785-97. DOI: 10.1016/0306-4522(89)90441-7. View

14.

Festing M, Altman D . Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 2002; 43(4):244-58. DOI: 10.1093/ilar.43.4.244. View

15.

He W, Jing X, Zhu B, Zhu X, Li L, Bai W . The auriculo-vagal afferent pathway and its role in seizure suppression in rats. BMC Neurosci. 2013; 14:85. PMC: 3751281. DOI: 10.1186/1471-2202-14-85. View

16.

Asamoto S, TAKESHIGE C . Activation of the satiety center by auricular acupuncture point stimulation. Brain Res Bull. 1992; 29(2):157-64. DOI: 10.1016/0361-9230(92)90021-o. View

17.

Kong J, Fang J, Park J, Li S, Rong P . Treating Depression with Transcutaneous Auricular Vagus Nerve Stimulation: State of the Art and Future Perspectives. Front Psychiatry. 2018; 9:20. PMC: 5807379. DOI: 10.3389/fpsyt.2018.00020. View

18.

Hamman R, Wing R, Edelstein S, Lachin J, Bray G, Delahanty L . Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006; 29(9):2102-7. PMC: 1762038. DOI: 10.2337/dc06-0560. View

19.

Li H, Zhang J, Xu C, Tang Q, Shen W, Zhou J . Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet--induced obese rats. Nutrition. 2015; 31(11-12):1416-22. DOI: 10.1016/j.nut.2015.05.007. View

20.

Luiten P, Ter Horst G, Steffens A . The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol. 1987; 28(1):1-54. DOI: 10.1016/0301-0082(87)90004-9. View